<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02781636</url>
  </required_header>
  <id_info>
    <org_study_id>30-00136</org_study_id>
    <nct_id>NCT02781636</nct_id>
  </id_info>
  <brief_title>Protect Chronic Tibial Nerve Stimulator (CTNS) System</brief_title>
  <official_title>A European Trial to Assess the Efficacy of an Implantable Wireless Neuromodulation Device at the Tibial Nerve to Treat Urinary Urgency Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>StimGuard, LLC.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>StimGuard, LLC.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      30 patient Study. All patients implanted with StimGuard Protect System. Patient followed out
      to 90 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed therapy is called chronic tibial nerve stimulation (CTNS), which is a low-risk,
      minimally invasive chronic implant for the treatment of urgency urinary incontinence. CTNS
      works by the same mechanism as percutaneous tibial nerve stimulation (PTNS), but is provided
      for chronic use with an implantable device. CTNS treatment involves the placement of a
      minimally invasive stimulator with an embedded receiver at the tibial nerve. The Protect CTNS
      System has an external transmitter that activates the implanted stimulator and sends mild
      electrical pulses to the tibial nerve. These impulses travel to the sacral nerve plexus, the
      group of nerves at the base of the spine responsible for bladder function. Since stimulation
      with the Protect CTNS System is chronic it is expected that bladder activity can be changed
      more quickly and without the frequency of treatments related to PTNS.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in Urge Incontinence Episodes</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Urge Incontinence</condition>
  <arm_group>
    <arm_group_label>Chronic Tibial Implant Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>StimGuard Protect System (Chronic Tibial Nerve Stimulation) Implant Procedure. Lead implanted adjacent to tibial nerve. Wireless rechargeable system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device: StimGuard Protect System</intervention_name>
    <description>Lead implanted adjacent to tibial nerve. Wireless rechargeable system.</description>
    <arm_group_label>Chronic Tibial Implant Arm</arm_group_label>
    <other_name>Chronic Afferent Nerve Stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of overactive bladder with urgency urinary incontinence

        Exclusion Criteria:

          -  Primary complaint of stress urinary incontinence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ailyn Chapman</last_name>
    <role>Study Director</role>
    <affiliation>StimGuard, LLC.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UZA</name>
      <address>
        <city>Edegern</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2016</study_first_submitted>
  <study_first_submitted_qc>May 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2016</study_first_posted>
  <last_update_submitted>December 23, 2016</last_update_submitted>
  <last_update_submitted_qc>December 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Efficacy</keyword>
  <keyword>Implantable</keyword>
  <keyword>Wireless</keyword>
  <keyword>Neuromodulation</keyword>
  <keyword>Device</keyword>
  <keyword>Tibial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence, Urge</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Upon Study Completion</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

